Clonal hematopoiesis is associated with future diseases and mortality

Area of Science:

• Genetics and Aging Research
• Cardiovascular and Hematological Diseases
• Epidemiology and Public Health

Background:

• Clonal hematopoiesis (CH) is recognized as a marker of aging.
• Clonal hematopoiesis of indeterminate potential (CHIP) is implicated as a risk factor for cardiovascular diseases, hematological malignancies, and mortality.
• The association of CHIP with diseases in other systems and cause-specific mortality requires further investigation.

Purpose of the Study:

• To investigate the longitudinal risks associated with CHIP for a wide range of common diseases and mortality causes.
• To explore the causal associations between CHIP and incident diseases using Mendelian randomization.
• To examine the combined effects of CHIP and telomere length (TL) on disease and mortality risks.

Main Methods:

• Utilized UK Biobank data from 431,546 participants to assess CHIP risks.
• Employed two-sample Mendelian randomization (MR) to determine causal links between CHIP and diseases.
• Applied Cox proportional hazard regression to calculate hazard ratios (HR) and confidence intervals (CI) for CHIP-related outcomes.

Main Results:

• CHIP was associated with increased risks for cancers, infections, ischemic heart diseases, blood, nervous, respiratory, and genitourinary system diseases, and related mortality.
• Elevated risks were also observed for mental and dermatological disorders, and circulatory system mortality.
• Associations remained robust after adjusting for inflammatory markers; larger clone sizes and TET2 mutations in CHIP conferred higher risks. Interactions with short telomere length were significant.

Conclusions:

• CHIP is associated with a broad spectrum of diseases and mortality across multiple organ systems.
• These findings reinforce CHIP's role as a potential risk factor impacting overall human health.
• Further research into CHIP's mechanisms and clinical implications is warranted.